# FDA Inspection 629452 - Penn Medicine Lancaster General Hospital - November 19, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/penn-medicine-lancaster-general-hospital/bf2b919b-f1a1-44e9-8395-967ab8f6bbb7
Source feed: FDA_Inspections

> FDA Inspection 629452 for Penn Medicine Lancaster General Hospital on November 19, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 629452
- Company Name: Penn Medicine Lancaster General Hospital
- Inspection Date: 2009-11-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1251732 - 2024-09-20](https://www.globalkeysolutions.net/records/fda_inspections/penn-medicine-lancaster-general-hospital/db4cab3d-56ef-4bf3-aec0-1cf8d622a344)
- [FDA Inspection 1251732 - 2024-09-20](https://www.globalkeysolutions.net/records/fda_inspections/penn-medicine-lancaster-general-hospital/6a7ae7d9-df21-4679-8129-f3c8a5673e12)
- [FDA Inspection 1069102 - 2018-08-30](https://www.globalkeysolutions.net/records/fda_inspections/penn-medicine-lancaster-general-hospital/1dca8660-8441-47e8-bc68-b15dca0a4e8c)
- [FDA Inspection 958060 - 2015-12-10](https://www.globalkeysolutions.net/records/fda_inspections/penn-medicine-lancaster-general-hospital/6ddd52ca-bd74-475b-81a7-1ba4f4b07a9f)
- [FDA Inspection 858513 - 2013-12-11](https://www.globalkeysolutions.net/records/fda_inspections/penn-medicine-lancaster-general-hospital/ed2ce98e-7b9d-4174-aed6-7ed49802217e)

Company: https://www.globalkeysolutions.net/companies/penn-medicine-lancaster-general-hospital/e5929e20-b602-4a69-b654-9910c12caa54

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d